Stabilizers, Silencers, and Disease Stage: Lessons From Recent Trials of ATTR Cardiac Amyloidosis.
Saved in:
| Title: | Stabilizers, Silencers, and Disease Stage: Lessons From Recent Trials of ATTR Cardiac Amyloidosis. |
|---|---|
| Authors: | Siddiqi HK; Department of Medicine, Division of Cardiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Bhatt K; Department of Medicine, Division of Cardiology, Emory University, Atlanta, Georgia, USA., Gopal DM; Department of Medicine, Section of Cardiovascular Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston Medical Center, Boston, Massachusetts, USA; Amyloidosis Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA., Siddiqi OK; Department of Medicine, Section of Cardiovascular Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston Medical Center, Boston, Massachusetts, USA; Amyloidosis Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA. Electronic address: omar.siddiqi@bmc.org. |
| Source: | Journal of the American College of Cardiology [J Am Coll Cardiol] 2026 Feb 10; Vol. 87 (5), pp. 502-504. Date of Electronic Publication: 2025 Dec 03. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
